MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-26-2026
Microbot Medical Total Shareholders Equity 2011-2026 | MBOT
Annual Total Shareholders Equity Microbot Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.6 M | 3.53 M | 4.5 M | 7.29 M | 14.4 M | 24.3 M | 31.5 M | 1.33 M | 9.96 M | 1.7 M | -64 K | 857 K | 375 K | 14 M | 10.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 77.6 M | -64 K | 13.5 M |
Quarterly Total Shareholders Equity Microbot Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.2 M | 30.4 M | 29 M | 3.53 M | 3.81 M | 6.06 M | 6.17 M | 4.5 M | 7.36 M | 9.47 M | 4.85 M | 7.29 M | 5.53 M | 8.54 M | 11.6 M | 14.4 M | 17.9 M | 20.1 M | 22.3 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 9.99 M | 9.96 M | 9.96 M | 9.96 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | -64 K | -334 K | -334 K | -334 K | 857 K | 5.87 M | 5.87 M | 5.87 M | 375 K | 15 M | 15 M | 15 M | 14 M | 14 M | 14 M | 14 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 78.2 M | -334 K | 12.3 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
25.4 B | $ 154.51 | -1.17 % | $ 44.4 B | USA |
 |
Repligen Corporation
RGEN
|
1.96 B | $ 117.78 | -0.46 % | $ 6.56 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 9.4 | -11.74 % | $ 22.8 M | USA |
 |
Haemonetics Corporation
HAE
|
821 M | $ 56.83 | 1.05 % | $ 2.86 B | USA |
 |
ICU Medical
ICUI
|
2.12 B | $ 123.31 | -1.53 % | $ 3.04 B | USA |
 |
Intuitive Surgical
ISRG
|
17.8 B | $ 452.07 | -2.67 % | $ 161 B | USA |
 |
Harvard Bioscience
HBIO
|
13.7 M | $ 5.2 | 2.16 % | $ 231 M | USA |
 |
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 10.31 | -13.65 % | $ 421 M | USA |
 |
Repro Med Systems
KRMD
|
17 M | $ 4.32 | 1.17 % | $ 200 M | USA |
 |
AtriCure
ATRC
|
492 M | $ 29.07 | 2.68 % | $ 1.39 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 23.0 | -0.13 % | $ 1.55 B | USA |
 |
InfuSystem Holdings
INFU
|
48 M | $ 9.29 | -0.11 % | $ 192 M | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 178.59 | 0.33 % | $ 9.52 B | USA |
 |
iRhythm Technologies
IRTC
|
153 M | $ 116.8 | -1.2 % | $ 3.74 B | USA |
 |
Merit Medical Systems
MMSI
|
1.58 B | $ 67.7 | -0.78 % | $ 4 B | USA |
 |
BioLife Solutions
BLFS
|
349 M | $ 19.51 | 1.14 % | $ 899 M | USA |
 |
electroCore
ECOR
|
-1.71 M | $ 6.8 | 3.03 % | $ 57.7 K | USA |
 |
STERIS plc
STE
|
6.6 B | $ 218.71 | -0.56 % | $ 21.6 B | USA |
 |
Teleflex Incorporated
TFX
|
3.12 B | $ 117.81 | -0.52 % | $ 5.26 B | USA |
 |
Utah Medical Products
UTMD
|
119 M | $ 63.12 | 0.4 % | $ 205 M | USA |
 |
OraSure Technologies
OSUR
|
341 M | $ 3.08 | 0.98 % | $ 226 M | USA |
 |
West Pharmaceutical Services
WST
|
3.18 B | $ 254.8 | 0.82 % | $ 18.4 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.63 | -0.26 % | $ 2.32 B | USA |
 |
Glaukos Corporation
GKOS
|
462 M | $ 112.77 | 0.12 % | $ 5.46 B | USA |
 |
ResMed
RMD
|
3.36 B | $ 224.09 | 0.56 % | $ 32.7 B | USA |
 |
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | USA |
 |
Baxter International
BAX
|
6.13 B | $ 16.68 | -0.6 % | $ 8.56 B | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
344 M | $ 20.21 | 4.55 % | $ 1 B | USA |
 |
Stereotaxis
STXS
|
13.5 M | $ 1.87 | 1.08 % | $ 170 M | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 70.17 | -1.76 % | $ 14 B | USA |
 |
LeMaitre Vascular
LMAT
|
394 M | $ 108.49 | -0.24 % | $ 2.46 B | USA |
 |
Nephros
NEPH
|
8.36 M | $ 2.87 | -2.21 % | $ 29.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
3.11 B | $ 25.81 | -0.35 % | $ 4.34 B | USA |
 |
Milestone Scientific
MLSS
|
2.81 M | $ 0.28 | -4.86 % | $ 23 M | USA |
 |
Alcon
ALC
|
18.8 B | $ 74.56 | -1.26 % | $ 40.4 B |  Schweiz |
 |
Pro-Dex
PDEX
|
36.6 M | $ 51.67 | 1.33 % | $ 170 M | USA |
 |
Retractable Technologies
RVP
|
74.4 M | $ 0.69 | 2.99 % | $ 20.7 M | USA |